RecruitingNCT07677696

Evaluating Midline Catheters in Clinical Practice

A Prospective, Multicenter, Real-World Clinical Study Provides an Assessment of the Safety and Efficacy of Midline Catheters


Sponsor

Shandong Branden Med.Device Co.,Ltd

Enrollment

10,000 participants

Start Date

May 1, 2026

Study Type

OBSERVATIONAL

Conditions

Summary

The goal of this observational study is to learn about the safety and effectiveness of midline catheters in patients who receive midline catheter placement as part of their routine clinical care. The main question it aims to answer is: Do midline catheters demonstrate acceptable safety and effectiveness when used in routine clinical practice? Participants who receive a midline catheter as part of their regular medical care will have their clinical data collected from electronic medical records and patient questionnaires, and followed for outcomes related to catheter-related complications and functional performance.


Eligibility

Min Age: 18 Years

Inclusion Criteria4

  • Age ≥ 18 years
  • First-time midline catheter placement per physician order
  • Not enrolled in another clinical study
  • Willing and able to provide informed consent and comply with follow-up (unless consent waived by local ethics committee)

Exclusion Criteria2

  • Deemed unsuitable by investigator (e.g., poor compliance or inability to communicate clearly)
  • Refusal of informed consent by patient or family member

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEMidline catheter placement

Patients receive a midline catheter as part of their routine clinical care for intravenous therapy lasting 1 to 4 weeks


Locations(1)

Zibo Central Hospital

Zibo, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07677696


Related Trials